EGCG
Green tea catechin studied for modest metabolic and cardiovascular benefits, with mixed clinical results and potential liver risk at high doses.
EGCG
Green tea catechin studied for modest metabolic and cardiovascular benefits, with mixed clinical results and potential liver risk at high doses.
Small, inconsistent benefits for weight and cholesterol — not a silver bullet, and high doses carry liver risk.
EGCG (epigallocatechin gallate) is the main catechin in green tea and matcha. It can influence oxidative stress, catecholamine breakdown, and metabolic signaling. Human studies show the most consistent effects are small reductions in LDL cholesterol and body weight, with weaker signals for blood pressure, glucose, and inflammation. It is most relevant for adults with higher cardiometabolic risk who want a modest, not dramatic, effect.
Proven Benefits
Protocol
Onset Time
Who Should Consider
Food Sources
- Brewed green tea (~50-100 mg EGCG per 240 mL cup)
- Matcha powder (~70-140 mg per gram, varies by grade)
- White tea (~30-50 mg per cup)
How It Works
EGCG weakly inhibits catechol-O-methyltransferase (COMT), which slows norepinephrine breakdown and may slightly increase thermogenesis. It also affects AMPK and other signaling pathways involved in lipid handling, glucose regulation, and oxidative stress.